Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disseminated mucocutaneous blastomycosis in a immunocompetent Indian patient.
Verma KK, Lakhanpal S, Sirka CS, D'souza P, Khaitan BB, Banerjee U. Verma KK, et al. Among authors: lakhanpal s. J Eur Acad Dermatol Venereol. 2000 Jul;14(4):332-3. doi: 10.1046/j.1468-3083.2000.00097-14.x. J Eur Acad Dermatol Venereol. 2000. PMID: 11204539 No abstract available.
Primary cutaneous actinomycosis.
Verma KK, Lakhanpal S, Sirka CS, Khaitan BK, Ramam M, Banerjee U. Verma KK, et al. Among authors: lakhanpal s. Acta Derm Venereol. 1999 Jul;79(4):327. doi: 10.1080/000155599750010805. Acta Derm Venereol. 1999. PMID: 10429998 Free article. No abstract available.
Primary cutaneous aspergillosis in an immunocompetent host.
Lakhanpal S, Pandhi RK, Khaitan BK, Iyer VK, Bannerjee U. Lakhanpal S, et al. Acta Derm Venereol. 2000 Jan-Feb;80(1):74-5. doi: 10.1080/000155500750012711. Acta Derm Venereol. 2000. PMID: 10721853 Free article. No abstract available.
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study.
Fleischmann RM, Saikali W, Lakhanpal S, Alvarez DF, Cox DS, Ianos CA, Zhang W, Cronenberger C, Wang K. Fleischmann RM, et al. Among authors: lakhanpal s. Lancet Rheumatol. 2023 Sep;5(9):e532-e541. doi: 10.1016/S2665-9913(23)00161-3. Epub 2023 Aug 21. Lancet Rheumatol. 2023. PMID: 38251497 Clinical Trial.
Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study.
Blum JL, DiCristo C, Gordon D, Karuturi MS, Oubre D, Jepsen E, Cuevas J, Lakhanpal S, Montelongo MZ, Zhang Z, Cappelleri JC, Wang Y, Tripathy D. Blum JL, et al. Among authors: lakhanpal s. Breast Cancer Res Treat. 2024 Feb;203(3):463-475. doi: 10.1007/s10549-023-07145-1. Epub 2023 Oct 30. Breast Cancer Res Treat. 2024. PMID: 37903899 Free PMC article.
89 results